Developer docs
API playgroundTry for free, no card

Search company profiles

CRScube

Full company profile

uuid0008edx

Namestring
CRScube
Legal namestring
CRScube Inc.
Websiteurl
crscube.io
Company typeenum
Private
Founded yearint
2011
Descriptiontext

CRScube Inc. is a Seoul-headquartered SaaS provider of eClinical software for clinical trials, founded in 2011 and serving pharmaceutical, biotechnology, medical device, and contract research organization (CRO) customers globally. Its core product is cubeCDMS, an electronic data capture (EDC) platform, extended by a unified suite covering pharmacovigilance (cubeSAFETY), randomization and trial supply management (cubeIWRS), direct data capture (cubeDDC), electronic patient-reported outcomes (cubePRO) with the cubeBUILDER configuration tool, electronic consent (cubeCONSENT), clinical trial management (cubeCTMS), trial master file (cubeTMF), risk-based quality management (cubeRBQM), and a learning management system (cubeLMS). The platform is cloud-based on AWS infrastructure with primary data centers in Tokyo and Seoul and disaster recovery in AWS Oregon, accessed via web browser without installation. CRScube holds broad regulatory and quality certifications including FDA 21 CFR Part 11, EMA computerized systems compliance, ISPE GAMP 5, CDISC ODM Platinum membership, WHODrug B3/C3, ISO/IEC 27001:2022, and ISO 9001:2015, and reported FDA inspections of cubeSAFETY and cubeCDMS in 2024 with zero system-related findings. The company is developing an AI-led EDC builder that processes PDF protocols via NLP to automatically generate study databases and compress traditional 8-12 week study build cycles.

The business operates a direct enterprise SaaS sales model with regional offices in Seoul, Minnetonka (US, established via the November 2025 acquisition of Mednet Solutions Inc.), Shanghai, Tokyo, and London. Revenue is generated through annual subscriptions to the unified eClinical platform, complemented by professional services for implementation, training (including the Train-the-Builder program), biometrics, and customer support. Customers include global pharmaceutical firms, mid-size biotech, large CROs (e.g., Linical, EPS), and the top five Korean pharmaceutical companies, with documented outcomes including 50-60% direct cost reductions versus legacy EDC vendors, 80% safety reporting budget reductions for biotech adopters, and 99.99%+ platform uptime. The company is bootstrapped with no venture capital or institutional investment, reported $7.6M in ARR and a $22.8M valuation as of 2025, and aggregates a track record of approximately 8,400 studies, 182,000 site users, 2.6 million patients, and 350+ regulatory approvals since 2010.

The Mednet acquisition in November 2025 is the most consequential recent move, combining CRScube's established Asia-Pacific position (6,000+ pre-acquisition trials) with Mednet's North American footprint (100+ FDA approvals supported) and transforming the go-to-market into a true global eClinical platform. Distribution combines direct enterprise field sales, a formal partner channel program with train-the-builder enablement, and self-service web access for mid-market adoption. Pricing is quote-based and not publicly disclosed. CRScube positions itself as an affordable, cost-effective alternative to legacy eClinical vendors, with a value proposition grounded in single sign-on platform integration, multi-regulatory compliance, and AI-assisted study build automation.

Short descriptiontext

CRScube is a bootstrapped Seoul-headquartered SaaS provider of unified eClinical solutions, including EDC, pharmacovigilance, RTSM, ePRO, CTMS, eTMF, and RBQM, serving pharmaceutical, biotechnology, medical device, and CRO customers globally, with AI-led EDC build automation in development.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic data capture, clinical trial management, eclinical platform, pharmacovigilance software, randomization and trial supply
Industry1 code
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
eClinical Software Platform
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscription - eClinical Platform
TypeSubscription Recurring
Description

CRScube generates revenue through annual SaaS subscriptions for its unified eClinical platform covering EDC, pharmacovigilance, RTSM, CTMS, eTMF, and patient-facing solutions. The subscription model includes software access, support, and maintenance with pricing based on study complexity and scope.

crscube.io
2Professional Services - Implementation & Training
TypeProfessional Services
Description

Revenue generated from implementation services, training programs (Train-the-builder program), and customer support services including study build instruction and biometrics services.

crscube.io
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Technology or R&D, Personnel
Pricing details1 tier
1Enterprise SaaS subscription with study-based or platform-level licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; no public pricing tiers published. Pricing remains consistent for the duration of MSA agreements with partners. The company positions itself as affordable and cost-effective compared to legacy vendors.

crscube.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

CRScube provides a unified, cloud-based eClinical SaaS platform for managing clinical trials. Its core offering centers on cubeCDMS for Electronic Data Capture, complemented by pharmacovigilance (cubeSAFETY), RTSM (cubeIWRS), direct data capture (cubeDDC), ePRO (cubePRO), eConsent (cubeCONSENT), CTMS, eTMF, RBQM, LMS, and AI-led automation tools. The company also offers professional services including biometrics, eClinical setup, medical writing, and customer support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • EDC setup timelines compressed from 8-12 weeks to a fraction of that time using AI-led EDC builder
+5 more records
Product overview1 text field

CRScube offers a unified eClinical platform combining multiple interconnected solutions: cubeCDMS as the core Electronic Data Capture (EDC) system, supplemented by site-focused solutions (cubeIWRS for randomization and supply management, cubeDDC for direct data capture), patient-facing tools (cubePRO for ePRO, cubeCONSENT for eConsent), trial team management (cubeCTMS, cubeTMF, cubeRBQM, cubeLMS), pharmacovigilance (cubeSAFETY), and AI-powered automation capabilities. All solutions are accessible via web browser without installation, operate on a SaaS model, and can be used independently or as a unified platform.

Product and service9 records
1cubeCDMS
CategoryElectronic Data Capture (EDC)
Description

CRScube's flagship Electronic Data Capture (EDC) platform that enables convenient and efficient management of clinical data with accurate eCRF data collection. Serves as the cornerstone of the unified eClinical platform for clinical trial sponsors and CROs.

2cubeSAFETY
CategoryPharmacovigilance
Description

Pharmacovigilance solution that simplifies adverse event reporting and reduces workload. Complies with FDA, EMA, PMDA, NMPA, and MFDS regulations, automates case processing, and integrates with EDC systems.

3cubeIWRS
CategoryRandomization and Trial Supply Management (RTSM/IWRS)
Description

Interactive Web Response System (RTSM) offering integrated functionalities for investigational products from randomization to IP return. Seamlessly integrates with cubeCDMS for accurate and streamlined IP-related tasks on a single platform.

4cubeDDC
CategoryeSource / Direct Data Capture
Description

Direct Data Capture solution that collects high-quality clinical data without the need for paper source documents, eliminating double data entry and ensuring data reliability.

5cubePRO
CategoryElectronic Patient-Reported Outcomes (ePRO)
Description

Electronic Patient Reported Outcomes (ePRO) solution for patient-centric data collection. Questionnaires are easily set up using cubeBUILDER with edit checks ensuring clean data, and ePRO data automatically synchronizes to cubeCDMS.

6cubeCONSENT
CategoryElectronic Informed Consent (eConsent)
Description

Electronic informed consent solution that streamlines the informed consent process for clinical trial participants. Participants consent via eSignatures which investigators review for final signature.

7cubeCTMS
CategoryClinical Trial Management System (CTMS)
Description

Clinical Trial Management System providing comprehensive view and management of overall trial progress and operational milestones, enabling central monitoring.

8cubeTMF
CategoryElectronic Trial Master File (eTMF)
Description

Trial Master File solution providing a validated paperless clinical trial environment compliant with FDA CFR 21 Part 11. Automated workflows reduce time and cost of managing documents.

9cubeRBQM
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-18
Description

CRScube completed the acquisition of Mednet, a US-based eClinical technology company specializing in electronic data capture. The transaction combines CRScube's strong Asian market position (6,000+ trials worldwide) with Mednet's established North American presence (100+ FDA approvals), creating a unified global eClinical platform. Both companies will continue serving existing clients while aligning operations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Veeva offers Vault CTMS, Vault EDC and the broader Vault Clinical Operations suite that directly competes with CRScube's unified eClinical platform. Both target pharma and CRO customers with SaaS clinical trial technology, making Veeva the most direct large-scale comparable.

TypeDirect peer
Description

Medidata's Rave EDC, Rave RTSM, Rave CTMS and Rave eTMF overlap directly with cubeCDMS, cubeIWRS, cubeCTMS and cubeTMF. Medidata is the legacy enterprise leader in EDC and a primary competitor for large pharma CRO contracts.

3Oracle Health Sciences (Clinical One)
TypeBroad incumbent
Description

Oracle's Clinical One platform competes with CRScube's unified eClinical suite across EDC, RTSM and CTMS. As a broader enterprise software incumbent with massive R&D and global infrastructure, Oracle competes at the top end of the market where CRScube seeks to expand.

TypeDirect peer
Description

Castor offers a cloud EDC platform with ePRO, eConsent and CTMS extensions targeting academic, biotech and CRO customers. Direct overlap with CRScube's mid-market positioning and similar self-service plus enterprise hybrid GTM motion.

TypeDirect peer
Description

Medrio provides an EDC-centric SaaS platform with ePRO, eConsent and RTSM, targeting pharma, biotech and CRO customers. Highly comparable in product scope and mid-market orientation, and a direct competitor for cubeCDMS sales.

TypeDirect peer
Description

Signant Health offers an eClinical suite covering EDC, ePRO, RTSM, eCOA and patient engagement that mirrors CRScube's modular offering. Serves overlapping pharma and biotech customer segments with similar unified-platform value propositions.

TypeDirect peer
Description

Clario delivers eClinical technology and clinical endpoint solutions including EDC, RTSM and eCOA. Direct overlap with CRScube's product set and a meaningful competitor for pharma and biotech trial technology contracts.

TypeDirect peer
Description

ArisGlobal's LifeSphere platform spans clinical, regulatory, safety (pharmacovigilance) and medical affairs. Overlaps directly with CRScube's cubeSAFETY and CTMS modules and competes for the same mid-to-large life sciences customers.

TypeBroad incumbent
Description

IQVIA combines CRO services with an eClinical technology portfolio that competes with CRScube's platform across EDC, RTSM and CTMS. As the largest CRO with proprietary technology, IQVIA is a broad incumbent that bundles services and software.

TypeEmerging player
Description

Formedix (now part of Instem) provides clinical trial design, CDISC standards automation and EDC build tools that overlap with CRScube's AI-led EDC builder and CDISC ODM-aligned offerings. Smaller-scale, niche player with partial overlap.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CRScube

eClinical Software Platformcrscube.io

CRScube is a bootstrapped Seoul-headquartered SaaS provider of unified eClinical solutions, including EDC, pharmacovigilance, RTSM, ePRO, CTMS, eTMF, and RBQM, serving pharmaceutical, biotechnology, medical device, and CRO customers globally, with AI-led EDC build automation in development.

What CRScube does

CRScube Inc. is a Seoul-headquartered SaaS provider of eClinical software for clinical trials, founded in 2011 and serving pharmaceutical, biotechnology, medical device, and contract research organization (CRO) customers globally. Its core product is cubeCDMS, an electronic data capture (EDC) platform, extended by a unified suite covering pharmacovigilance (cubeSAFETY), randomization and trial supply management (cubeIWRS), direct data capture (cubeDDC), electronic patient-reported outcomes (cubePRO) with the cubeBUILDER configuration tool, electronic consent (cubeCONSENT), clinical trial management (cubeCTMS), trial master file (cubeTMF), risk-based quality management (cubeRBQM), and a learning management system (cubeLMS). The platform is cloud-based on AWS infrastructure with primary data centers in Tokyo and Seoul and disaster recovery in AWS Oregon, accessed via web browser without installation. CRScube holds broad regulatory and quality certifications including FDA 21 CFR Part 11, EMA computerized systems compliance, ISPE GAMP 5, CDISC ODM Platinum membership, WHODrug B3/C3, ISO/IEC 27001:2022, and ISO 9001:2015, and reported FDA inspections of cubeSAFETY and cubeCDMS in 2024 with zero system-related findings. The company is developing an AI-led EDC builder that processes PDF protocols via NLP to automatically generate study databases and compress traditional 8-12 week study build cycles.

The business operates a direct enterprise SaaS sales model with regional offices in Seoul, Minnetonka (US, established via the November 2025 acquisition of Mednet Solutions Inc.), Shanghai, Tokyo, and London. Revenue is generated through annual subscriptions to the unified eClinical platform, complemented by professional services for implementation, training (including the Train-the-Builder program), biometrics, and customer support. Customers include global pharmaceutical firms, mid-size biotech, large CROs (e.g., Linical, EPS), and the top five Korean pharmaceutical companies, with documented outcomes including 50-60% direct cost reductions versus legacy EDC vendors, 80% safety reporting budget reductions for biotech adopters, and 99.99%+ platform uptime. The company is bootstrapped with no venture capital or institutional investment, reported $7.6M in ARR and a $22.8M valuation as of 2025, and aggregates a track record of approximately 8,400 studies, 182,000 site users, 2.6 million patients, and 350+ regulatory approvals since 2010.

The Mednet acquisition in November 2025 is the most consequential recent move, combining CRScube's established Asia-Pacific position (6,000+ pre-acquisition trials) with Mednet's North American footprint (100+ FDA approvals supported) and transforming the go-to-market into a true global eClinical platform. Distribution combines direct enterprise field sales, a formal partner channel program with train-the-builder enablement, and self-service web access for mid-market adoption. Pricing is quote-based and not publicly disclosed. CRScube positions itself as an affordable, cost-effective alternative to legacy eClinical vendors, with a value proposition grounded in single sign-on platform integration, multi-regulatory compliance, and AI-assisted study build automation.

CRScube firmographics

Firmographics
Name
CRScube
Legal name
CRScube Inc.
Website
https://crscube.io
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
CRScube is a bootstrapped Seoul-headquartered SaaS provider of unified eClinical solutions, including EDC, pharmacovigilance, RTSM, ePRO, CTMS, eTMF, and RBQM, serving pharmaceutical, biotechnology, medical device, and CRO customers globally, with AI-led EDC build automation in development.
Ownership category
akta.pro rank

CRScube industry classification

Industry
Product category
eClinical Software Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs

Keywords

  • Electronic data capture
  • Clinical trial management
  • Eclinical platform
  • Pharmacovigilance software
  • Randomization and trial supply

Where CRScube is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices5 records

Markets served

CRScube business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel

Revenue model

  1. SaaS Subscription - eClinical Platform: CRScube generates revenue through annual SaaS subscriptions for its unified eClinical platform covering EDC, pharmacovigilance, RTSM, CTMS, eTMF, and patient-facing solutions. The subscription model includes software access, support, and maintenance with pricing based on study complexity and scope.
  2. Professional Services - Implementation & Training: Revenue generated from implementation services, training programs (Train-the-builder program), and customer support services including study build instruction and biometrics services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription with study-based or platform-level licensing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

CRScube product offering

Product offering

Core offering

CRScube provides a unified, cloud-based eClinical SaaS platform for managing clinical trials. Its core offering centers on cubeCDMS for Electronic Data Capture, complemented by pharmacovigilance (cubeSAFETY), RTSM (cubeIWRS), direct data capture (cubeDDC), ePRO (cubePRO), eConsent (cubeCONSENT), CTMS, eTMF, RBQM, LMS, and AI-led automation tools. The company also offers professional services including biometrics, eClinical setup, medical writing, and customer support.

Product overview

CRScube offers a unified eClinical platform combining multiple interconnected solutions: cubeCDMS as the core Electronic Data Capture (EDC) system, supplemented by site-focused solutions (cubeIWRS for randomization and supply management, cubeDDC for direct data capture), patient-facing tools (cubePRO for ePRO, cubeCONSENT for eConsent), trial team management (cubeCTMS, cubeTMF, cubeRBQM, cubeLMS), pharmacovigilance (cubeSAFETY), and AI-powered automation capabilities. All solutions are accessible via web browser without installation, operate on a SaaS model, and can be used independently or as a unified platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • cubeCDMS CRScube's flagship Electronic Data Capture (EDC) platform that enables convenient and efficient management of clinical data with accurate eCRF data collection. Serves as the cornerstone of the unified eClinical platform for clinical trial sponsors and CROs.
  • cubeSAFETY Pharmacovigilance solution that simplifies adverse event reporting and reduces workload. Complies with FDA, EMA, PMDA, NMPA, and MFDS regulations, automates case processing, and integrates with EDC systems.
  • cubeIWRS Interactive Web Response System (RTSM) offering integrated functionalities for investigational products from randomization to IP return. Seamlessly integrates with cubeCDMS for accurate and streamlined IP-related tasks on a single platform.
  • cubeDDC Direct Data Capture solution that collects high-quality clinical data without the need for paper source documents, eliminating double data entry and ensuring data reliability.
  • cubePRO Electronic Patient Reported Outcomes (ePRO) solution for patient-centric data collection. Questionnaires are easily set up using cubeBUILDER with edit checks ensuring clean data, and ePRO data automatically synchronizes to cubeCDMS.
  • cubeCONSENT Electronic informed consent solution that streamlines the informed consent process for clinical trial participants. Participants consent via eSignatures which investigators review for final signature.
  • cubeCTMS Clinical Trial Management System providing comprehensive view and management of overall trial progress and operational milestones, enabling central monitoring.
  • cubeTMF Trial Master File solution providing a validated paperless clinical trial environment compliant with FDA CFR 21 Part 11. Automated workflows reduce time and cost of managing documents.
  • cubeRBQM

Quantifiable outcome

  • EDC setup timelines compressed from 8-12 weeks to a fraction of that time using AI-led EDC builder
  • +5 more outcomes

Companies that use CRScube

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles4 records

CRScube technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

CRScube partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Mednet Solutions Inc.coreStrategic or Co-development Partner · 18 November 2025CRScube completed the acquisition of Mednet, a US-based eClinical technology company specializing in electronic data capture. The transaction combines CRScube's strong Asian market position (6,000+ trials worldwide) with Mednet's established North American presence (100+ FDA approvals), creating a unified global eClinical platform. Both companies will continue serving existing clients while aligning operations.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

CRScube competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva offers Vault CTMS, Vault EDC and the broader Vault Clinical Operations suite that directly competes with CRScube's unified eClinical platform. Both target pharma and CRO customers with SaaS clinical trial technology, making Veeva the most direct large-scale comparable.
  • Medidata Solutions (Dassault Systèmes): Medidata's Rave EDC, Rave RTSM, Rave CTMS and Rave eTMF overlap directly with cubeCDMS, cubeIWRS, cubeCTMS and cubeTMF. Medidata is the legacy enterprise leader in EDC and a primary competitor for large pharma CRO contracts.
  • Castor: Castor offers a cloud EDC platform with ePRO, eConsent and CTMS extensions targeting academic, biotech and CRO customers. Direct overlap with CRScube's mid-market positioning and similar self-service plus enterprise hybrid GTM motion.
  • Medrio: Medrio provides an EDC-centric SaaS platform with ePRO, eConsent and RTSM, targeting pharma, biotech and CRO customers. Highly comparable in product scope and mid-market orientation, and a direct competitor for cubeCDMS sales.
  • Signant Health: Signant Health offers an eClinical suite covering EDC, ePRO, RTSM, eCOA and patient engagement that mirrors CRScube's modular offering. Serves overlapping pharma and biotech customer segments with similar unified-platform value propositions.
  • Clario: Clario delivers eClinical technology and clinical endpoint solutions including EDC, RTSM and eCOA. Direct overlap with CRScube's product set and a meaningful competitor for pharma and biotech trial technology contracts.
  • ArisGlobal: ArisGlobal's LifeSphere platform spans clinical, regulatory, safety (pharmacovigilance) and medical affairs. Overlaps directly with CRScube's cubeSAFETY and CTMS modules and competes for the same mid-to-large life sciences customers.

Broad incumbents

  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform competes with CRScube's unified eClinical suite across EDC, RTSM and CTMS. As a broader enterprise software incumbent with massive R&D and global infrastructure, Oracle competes at the top end of the market where CRScube seeks to expand.
  • IQVIA (Technology & eClinical): IQVIA combines CRO services with an eClinical technology portfolio that competes with CRScube's platform across EDC, RTSM and CTMS. As the largest CRO with proprietary technology, IQVIA is a broad incumbent that bundles services and software.

Emerging players

  • Formedix (Instem): Formedix (now part of Instem) provides clinical trial design, CDISC standards automation and EDC build tools that overlap with CRScube's AI-led EDC builder and CDISC ODM-aligned offerings. Smaller-scale, niche player with partial overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

CRScube social profiles

Digital presence

CRScube compliance and trust

Trust signal

Compliance7 records

CRScube financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CRScube leadership team

Management profile

Number of profiles

Profiles7 records

CRScube subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

CRScube funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CRScube M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRScube

What does CRScube do?

CRScube provides a unified, cloud-based eClinical SaaS platform for managing clinical trials. Its core offering centers on cubeCDMS for Electronic Data Capture, complemented by pharmacovigilance (cubeSAFETY), RTSM (cubeIWRS), direct data capture (cubeDDC), ePRO (cubePRO), eConsent (cubeCONSENT), CTMS, eTMF, RBQM, LMS, and AI-led automation tools. The company also offers professional services including biometrics, eClinical setup, medical writing, and customer support.

Is CRScube a public or private company?

CRScube is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CRScube founded?

CRScube was founded in 2011. It employs 51 to 100 people.

Where is CRScube based?

CRScube is headquartered in Seoul, South Korea, in the Asia region.

How does CRScube make money?

Two revenue lines are on record. SaaS Subscription - eClinical Platform is the primary driver. The others are professional Services - Implementation & Training.

Who are CRScube's main competitors?

Direct peers on record are Veeva Systems, Medidata Solutions (Dassault Systèmes), Castor, Medrio, Signant Health, Clario and ArisGlobal. Broad incumbents are Oracle Health Sciences (Clinical One) and IQVIA (Technology & eClinical). Formedix (Instem) is listed as an emerging player.

Does CRScube have an API?

No public API is recorded for CRScube.

What industry is CRScube in?

CRScube's product category is eClinical Software Platform. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 5182 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Clinical Trials ArenaClinical trials: Are data managers ready for AI in EDC?The article examines how AI is transforming clinical trial data management and electronic data capture (EDC) systems, noting that adoption remains slow due to the industry's risk-averse culture, regulatory compliance requirements, and skepticism stemming from unmet vendor promises. CRScube is highlighted as an example of a company that has successfully integrated AI into its EDC framework through targeted implementation rather than complete process overhaul, reducing adoption risk while delivering operational value. The piece advises clinical organizations to invest in change management and redefine data manager roles as the industry transitions toward AI-automated workflows.Pharmaceutical TechnologyHow the AI shift is happening now in data managementAI-driven tools are increasingly being applied to electronic data capture (EDC) build processes in clinical trials, automating database setup that traditionally takes weeks and shifting data managers toward oversight and validation roles. CRScube is developing an AI-led EDC builder that processes PDF protocols to automatically generate structured database environments, aiming to compress study start-up timelines significantly. The article notes that organizations will need to adapt their operating models, skill frameworks, and governance structures to accommodate AI-driven database builds.Clinical Trials ArenaThe advantages of a platform approach in clinical trial data managementThis article examines the challenges pharmaceutical companies face managing increasingly complex clinical trial data with traditional fragmented tools and manual processes. It argues that unified platform-based approaches offer advantages including automated data cleaning, improved collaboration across teams, better scalability, and simplified regulatory compliance through built-in audit trails. The article specifically highlights CRScube's integrated data management platform as an example of this unified approach, though it reads as promotional content for their suite of products.Pharmaceutical TechnologyOncology trials: Precision and reliability in data managementCRScube published a case study detailing how its electronic data capture platform helped a bio-venture company manage complex data workflows in an oncology clinical trial. The platform provided integrated imaging management, RECIST/iRECIST evaluations, and automated response calculations while addressing challenges including dynamic study designs with multiple protocol changes. The case study highlights the importance of data integrity and workflow flexibility in oncology trials where incomplete or unreliable data can undermine trial credibility and increase costs.BioXconomyCRScube acquires Mednet to expand clinical trial techSouth Korean eClinical tech firm CRScube has acquired US-based Mednet to expand its presence in the North American clinical trials market, combining their electronic data capture, randomization, supply management, ePRO, CTMS, and eTMF portfolios. Financial terms of the deal were not disclosed, though CRScube CEO cited geographic expansion as the motivation behind the acquisition. Both companies will continue serving existing clients while working to align operations and explore integration opportunities.The Manila TimesCRScube acquires Mednet to expand global eClinical capabilitiesCRScube acquired Mednet, expanding into the North American market. The combined eClinical suite includes EDC, RTSM, ePRO, CTMS, and eTMF, supporting 6,000+ trials and 560,000+ participants. The companies will align operations and explore integration opportunities.CrscubeCRScube acquires Mednet to expand global eClinical capabilitiesCRScube, Korea's leading eClinical technology provider, has completed its acquisition of US-based Mednet, a transaction announced on November 18, 2025, representing CRScube's strategic expansion into the North American market. The deal unites two established eClinical vendors—CRScube with 6,000+ trials supported globally and Mednet with over 100 FDA approvals facilitated—creating a combined platform offering EDC, RTSM, ePRO, CTMS, and eTMF solutions. The merged organization will leverage CRScube's Asian market leadership alongside Mednet's North American client relationships and operational expertise to deliver a unified global approach to clinical trial technology.